Get started
Author

Joe Wei

Anti-vascular endothelial growth factor for neovascular age-related macular degeneration: a meta-analysis of randomized controlled trials
2018 · Chu Luan Nguyen, Lawrence J. Oh, et al. · BMC Ophthalmology · 53
CDKN2A/B Homozygous Deletions in Astrocytomas: A Literature Review
2023 · Alexander Yuile, Laveniya Satgunaseelan, et al. · Current Issues in Molecular Biology · 37
PDF
Influenza A Infection Enhances Cross-Priming of CD8+ T Cells to Cell-Associated Antigens in a TLR7- and Type I IFN-Dependent Fashion
2010 · Joe Wei, Jason Waithman, et al. · The Journal of Immunology · 29
PDF
Lentivector immunization induces tumor antigen‐specific B and T cell responses in vivo
2008 · Javier Garcia Casado, Jozef Janda, et al. · European Journal of Immunology · 23
PDF
Pathological response guides adjuvant 5-fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) chemotherapy in surgically resected gastro-oesophageal cancer (SPACE-FLOT): international cohort study
2025 · SPACE-FLOT Investigators, David S Liu, et al. · British journal of surgery · 18
Real world efficacy and toxicity of consolidation durvalumab following chemoradiotherapy in older Australian patients with unresectable stage III non-small cell lung cancer
2024 · Samuel Stevens, Udit Nindra, et al. · Journal of Geriatric Oncology · 16
PDF
Implications of Concurrent IDH1 and IDH2 Mutations on Survival in Glioma—A Case Report and Systematic Review
2022 · Alexander Yuile, Laveniya Satgunaseelan, et al. · Current Issues in Molecular Biology · 12
PDF
Dynamic quantification of MHC class I–peptide presentation to CD8+ T cells via intracellular cytokine staining
2006 · Ken C. Pang, Joe Q.Z. Wei, et al. · Journal of Immunological Methods · 11
LOREALAUS: LOrlatinib REAL-World AUStralian Experience in Advanced ALK-Rearranged NSCLC
2023 · Marliese Alexander, Joe Wei, et al. · JTO Clinical and Research Reports · 10
PDF
Men’s health on the web: an analysis of current resources
2019 · Jiasian Teh, Joe Wei, et al. · World Journal of Urology · 10
Outcomes following long-term disease control with immune checkpoint inhibitors in patients with advanced melanoma
2024 · Eleanor E. Handel, Janet McKeown, et al. · European Journal of Cancer · 8
Therapeutic drug monitoring of osimertinib in EGFR mutant non‐small cell lung cancer by dried blood spot and plasma collection: A pilot study
2024 · Sathya Narayanan, Alexander Yuile, et al. · British Journal of Clinical Pharmacology · 8
PDF
PSMA Expression Correlates with Improved Overall Survival and VEGF Expression in Glioblastoma
2023 · Alexander Yuile, Adrian Lee, et al. · Biomedicines · 7
PDF
First-line chemoimmunotherapy and immunotherapy in patients with non-small cell lung cancer and brain metastases: a registry study
2024 · Lauren Julia Brown, Victor Khou, et al. · Frontiers in Oncology · 5
Interdependencies of the Neuronal, Immune and Tumor Microenvironment in Gliomas
2023 · Alexander Yuile, Joe Q. Wei, et al. · Cancers · 5
PDF
Assessing Patient-Reported Financial, Social, and Time Toxicity in Early-Phase Cancer Clinical Trials in Australia Through a Prospective Multicenter Nonrandomized Cohort Study
2025 · Udit Nindra, Joanne Tang, et al. · JCO Oncology Practice · 4
Clinical outcomes and management of CDKN2A/B homozygously deleted IDH-mutant astrocytomas—a cohort study and patterns of care survey
2025 · Alexander Yuile, Laveniya Satgunaseelan, et al. · Neuro-Oncology Practice · 4
PDF
Evaluating patient diversity in early phase clinical trials in Australia through a prospective multicenter nonrandomized cohort study
2025 · Udit Nindra, Joanne Tang, et al. · JNCI Cancer Spectrum · 3
1496 JSKN033, an innovative subcutaneous-injected fixed-dose combination (FDC) of biparatopic anti-HER2 antibody drug conjugate (ADC) and PD-L1 inhibitor in advanced solid tumor
2024 · Charlotte Lemech, Joe Wei, et al. · 3
Anti-PD-1 Monoclonal Antibodies (mAbs) Are Superior to Anti-PD-L1 mAbs When Combined with Chemotherapy in First-Line Treatment for Metastatic Non-Small Cell Lung Cancer (mNSCLC): A Network Meta-Analysis
2023 · Joe Wei, Alexander Yuile, et al. · Biomedicines · 3
PDF
Optimal conditions required for influenza A infection‐enhanced cross‐priming of CD8+ T cells specific to cell‐associated antigens
2013 · Joe Wei, Jason Waithman, et al. · Immunology and Cell Biology · 2
PDF
Network-Integrated Platform for Clinical Trial Navigation from the New South Wales Early Phase Clinical Trials Alliance
2026 · Jia Liu, Max Farrow, et al. · Clinical Cancer Research · 1
Prospective assessment of health-related quality of life in early phase oncology clinical trials: PEARLER
2025 · Udit Nindra, Joanne Tang, et al. · JNCI Cancer Spectrum · 1
PDF
Vaccine-induced immunity is maintained in glioma patients relative to other solid tumours
2025 · Alexander Yuile, Joe Q. Wei, et al. · Journal of Neuro-Oncology · 1
PDF
A protocol for pretreatment testing for antibodies to galactose-alpha-1,3-galactose to mitigate the risk of cetuximab hypersensitivity reactions.
2025 · Nicholas Della Marta, Alexander Yuile, et al. · Journal of Clinical Oncology · 1
Works count: 41
Citation count: 277
H-index: 10
I10-index: 10
Year
Topic
Type